Literature DB >> 7943455

Clinical symptoms associated with age at onset in Alzheimer's disease.

B A Lawlor1, T M Ryan, J Schmeidler, R C Mohs, K L Davis.   

Abstract

OBJECTIVE: The aim of the study was to examine the relationship between age at onset of Alzheimer's disease and demographic and clinical characteristics in a large cohort of patients with Alzheimer's disease.
METHOD: The subjects were 104 patients meeting the criteria for Alzheimer's disease of the National Institute of Neurological and Communicative Disorders and Stroke. The relationships of age at disease onset to cognitive and noncognitive variables and to rate of progression were explored by using multiple regression analysis.
RESULTS: Earlier disease onset was associated with the presence of greater language and praxis difficulties and with the development of higher depression scores during the follow-up study period but not with faster disease progression.
CONCLUSIONS: These findings suggest that in Alzheimer's disease, which is a clinically heterogeneous illness, younger age at onset may be related to the presence of more prominent language and praxis impairment and to development of greater depression during the disease course.

Entities:  

Mesh:

Year:  1994        PMID: 7943455     DOI: 10.1176/ajp.151.11.1646

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings.

Authors:  Sonia J Lupien; Georges Schwartz; Ying Kin Ng; Alexandra Fiocco; Nathalie Wan; Jens C Pruessner; Michael J Meaney; N P Vasavan Nair
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

2.  Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.

Authors:  L Mosconi; K Herholz; I Prohovnik; B Nacmias; M T R De Cristofaro; M Fayyaz; L Bracco; S Sorbi; A Pupi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 3.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

4.  Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

Authors:  C Haense; K Herholz; W J Jagust; W D Heiss
Journal:  Dement Geriatr Cogn Disord       Date:  2009-09-25       Impact factor: 2.959

5.  Differences between Early and Late-Onset Alzheimer's Disease in Neuropsychological Tests.

Authors:  Francisca Sá; Paula Pinto; Catarina Cunha; Raquel Lemos; Liliana Letra; Mário Simões; Isabel Santana
Journal:  Front Neurol       Date:  2012-05-14       Impact factor: 4.003

6.  Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Authors:  Melisa Gumus; Namita Multani; Michael L Mack; Maria Carmela Tartaglia
Journal:  Geroscience       Date:  2021-01-09       Impact factor: 7.581

Review 7.  The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.

Authors:  John Moraros; Chijioke Nwankwo; Scott B Patten; Darrell D Mousseau
Journal:  Depress Anxiety       Date:  2016-12-28       Impact factor: 6.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.